Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008:
Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78.
Free full-text


  Alzheimer's Disease

  Free Subscription


Articles published in Arch Neurol

Retrieve available abstracts of 82 articles:
HTML format



Single Articles


    June 2008
  1. PETTERSEN JA , Sathiyamoorthy G, Gao FQ, Szilagyi G, et al
    Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook Dementia Study.
    Arch Neurol. 2008;65:790-5.
    PubMed     Related articles    Abstract available


  2. LOCASCIO JJ , Fukumoto H, Yap L, Bottiglieri T, et al
    Plasma amyloid beta-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease.
    Arch Neurol. 2008;65:776-85.
    PubMed     Related articles    Abstract available


    May 2008

  3. Cognitive Function Over Time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a Randomized, Controlled Trial of Naproxen and Celecoxib.
    Arch Neurol. 2008;.
    PubMed     Related articles    Abstract available


  4. KUCZYNSKI B , Reed B, Mungas D, Weiner M, et al
    Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
    Arch Neurol. 2008;65:650-5.
    PubMed     Related articles    Abstract available


    April 2008
  5. BASUN H , Bogdanovic N, Ingelsson M, Almkvist O, et al
    Clinical and Neuropathological Features of the Arctic APP Gene Mutation Causing Early-Onset Alzheimer Disease.
    Arch Neurol. 2008;65:499-505.
    PubMed     Related articles    Abstract available


  6. REMES AM , Laru L, Tuominen H, Aalto S, et al
    Carbon 11-labeled pittsburgh compound B positron emission tomographic amyloid imaging in patients with APP locus duplication.
    Arch Neurol. 2008;65:540-4.
    PubMed     Related articles    Abstract available


  7. BIRD TD , Lipe HP, Steinbart EJ
    Geriatric neurogenetics: oxymoron or reality?
    Arch Neurol. 2008;65:537-9.
    PubMed     Related articles    Abstract available


    March 2008
  8. JAYADEV S , Steinbart EJ, Chi YY, Kukull WA, et al
    Conjugal Alzheimer disease: risk in children when both parents have Alzheimer disease.
    Arch Neurol. 2008;65:373-8.
    PubMed     Related articles    Abstract available


  9. WARING SC , Rosenberg RN
    Genome-wide association studies in Alzheimer disease.
    Arch Neurol. 2008;65:329-34.
    PubMed     Related articles    Abstract available


  10. SMALL SA
    Retromer sorting: a pathogenic pathway in late-onset Alzheimer disease.
    Arch Neurol. 2008;65:323-8.
    PubMed     Related articles    Abstract available


  11. RINGMAN JM , Rao PN, Lu PH, Cederbaum S, et al
    Mosaicism for trisomy 21 in a patient with young-onset dementia: a case report and brief literature review.
    Arch Neurol. 2008;65:412-5.
    PubMed     Related articles    Abstract available


    February 2008
  12. SUNDELOF J , Giedraitis V, Irizarry MC, Sundstrom J, et al
    Plasma {beta} Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men: A Prospective, Population-Based Cohort Study.
    Arch Neurol. 2008;65:256-63.
    PubMed     Related articles    Abstract available


  13. ROGALSKI E , Johnson N, Weintraub S, Mesulam M, et al
    Increased frequency of learning disability in patients with primary progressive aphasia and their first-degree relatives.
    Arch Neurol. 2008;65:244-8.
    PubMed     Related articles    Abstract available


    January 2008
  14. FOTENOS AF , Mintun MA, Snyder AZ, Morris JC, et al
    Brain volume decline in aging: evidence for a relation between socioeconomic status, preclinical Alzheimer disease, and reserve.
    Arch Neurol. 2008;65:113-20.
    PubMed     Related articles    Abstract available


  15. ROE CM , Xiong C, Grant E, Miller JP, et al
    Education and reported onset of symptoms among individuals with Alzheimer disease.
    Arch Neurol. 2008;65:108-11.
    PubMed     Related articles    Abstract available


  16. IRIE F , Fitzpatrick AL, Lopez OL, Kuller LH, et al
    Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE {varepsilon}4: The Cardiovascular Health Study Cognition Study.
    Arch Neurol. 2008;65:89-93.
    PubMed     Related articles    Abstract available


    December 2007
  17. COUNTS SE , He B, Che S, Ikonomovic MD, et al
    {alpha}7 Nicotinic Receptor Up-regulation in Cholinergic Basal Forebrain Neurons in Alzheimer Disease.
    Arch Neurol. 2007;64:1771-6.
    PubMed     Related articles    Abstract available


  18. SCARMEAS N , Brandt J, Blacker D, Albert M, et al
    Disruptive behavior as a predictor in Alzheimer disease.
    Arch Neurol. 2007;64:1755-61.
    PubMed     Related articles    Abstract available


  19. HELZNER EP , Scarmeas N, Cosentino S, Portet F, et al
    Leisure activity and cognitive decline in incident Alzheimer disease.
    Arch Neurol. 2007;64:1749-54.
    PubMed     Related articles    Abstract available


  20. GOMEZ-TORTOSA E , Barquero MS, Baron M, Sainz MJ, et al
    Variability of age at onset in siblings with familial Alzheimer disease.
    Arch Neurol. 2007;64:1743-8.
    PubMed     Related articles    Abstract available


  21. JOSEPHS KA
    Capgras syndrome and its relationship to neurodegenerative disease.
    Arch Neurol. 2007;64:1762-6.
    PubMed     Related articles    Abstract available


    November 2007
  22. LI H , Wetten S, Li L, St Jean PL, et al
    Candidate Single-Nucleotide Polymorphisms From a Genomewide Association Study of Alzheimer Disease.
    Arch Neurol. 2007;.
    PubMed     Related articles    Abstract available


  23. HINERFELD DA , Moonis M, Swearer JM, Baker SP, et al
    Statins differentially affect amyloid precursor protein metabolism in presymptomatic PS1 and non-PS1 subjects.
    Arch Neurol. 2007;64:1672-3.
    PubMed     Related articles   


    October 2007
  24. DORAN M , du Plessis DG, Ghadiali EJ, Mann DM, et al
    Familial early-onset dementia with tau intron 10 + 16 mutation with clinical features similar to those of Alzheimer disease.
    Arch Neurol. 2007;64:1535-9.
    PubMed     Related articles    Abstract available


  25. APOSTOLOVA LG , Steiner CA, Akopyan GG, Dutton RA, et al
    Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease.
    Arch Neurol. 2007;64:1489-95.
    PubMed     Related articles    Abstract available


  26. ALLEN G , Barnard H, McColl R, Hester AL, et al
    Reduced hippocampal functional connectivity in Alzheimer disease.
    Arch Neurol. 2007;64:1482-7.
    PubMed     Related articles    Abstract available


  27. MORENO H , Wu WE, Lee T, Brickman A, et al
    Imaging the abeta-related neurotoxicity of Alzheimer disease.
    Arch Neurol. 2007;64:1467-77.
    PubMed     Related articles    Abstract available


  28. BROUWERS N , Nuytemans K, van der Zee J, Gijselinck I, et al
    Alzheimer and Parkinson diagnoses in progranulin null mutation carriers in an extended founder family.
    Arch Neurol. 2007;64:1436-46.
    PubMed     Related articles    Abstract available


    September 2007
  29. HARRISON J , Minassian SL, Jenkins L, Black RS, et al
    A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Arch Neurol. 2007;64:1323-9.
    PubMed     Related articles    Abstract available


  30. IKONOMOVIC MD , Abrahamson EE, Isanski BA, Wuu J, et al
    Superior frontal cortex cholinergic axon density in mild cognitive impairment and early Alzheimer disease.
    Arch Neurol. 2007;64:1312-7.
    PubMed     Related articles    Abstract available


  31. WONG V
    Medication use as a confounding factor in the use of the cerebrospinal fluid tau/beta-amyloid42 ratio.
    Arch Neurol. 2007;64:1357.
    PubMed     Related articles   


    August 2007
  32. BERLAU DJ , Kahle-Wrobleski K, Head E, Goodus M, et al
    Dissociation of neuropathologic findings and cognition: case report of an apolipoprotein E epsilon2/epsilon2 genotype.
    Arch Neurol. 2007;64:1193-6.
    PubMed     Related articles    Abstract available


  33. NG SY , Villemagne VL, Masters CL, Rowe CC, et al
    Evaluating atypical dementia syndromes using positron emission tomography with carbon 11 labeled Pittsburgh Compound B.
    Arch Neurol. 2007;64:1140-4.
    PubMed     Related articles    Abstract available


  34. WHITWELL JL , Petersen RC, Negash S, Weigand SD, et al
    Patterns of atrophy differ among specific subtypes of mild cognitive impairment.
    Arch Neurol. 2007;64:1130-8.
    PubMed     Related articles    Abstract available


    July 2007
  35. MARSHALL GA , Monserratt L, Harwood D, Mandelkern M, et al
    Positron emission tomography metabolic correlates of apathy in Alzheimer disease.
    Arch Neurol. 2007;64:1015-20.
    PubMed     Related articles    Abstract available


  36. VAN DE POL LA , Korf ES, van der Flier WM, Brashear HR, et al
    Magnetic resonance imaging predictors of cognition in mild cognitive impairment.
    Arch Neurol. 2007;64:1023-8.
    PubMed     Related articles    Abstract available


  37. SCHUPF N , Patel B, Pang D, Zigman WB, et al
    Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.
    Arch Neurol. 2007;64:1007-13.
    PubMed     Related articles    Abstract available


  38. MARKESBERY WR , Lovell MA
    Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment.
    Arch Neurol. 2007;64:954-6.
    PubMed     Related articles    Abstract available


    June 2007
  39. RIDHA BH , Barnes J, van de Pol LA, Schott JM, et al
    Application of automated medial temporal lobe atrophy scale to Alzheimer disease.
    Arch Neurol. 2007;64:849-54.
    PubMed     Related articles    Abstract available


    May 2007
  40. PICCINI A , Zanusso G, Borghi R, Noviello C, et al
    Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype.
    Arch Neurol. 2007;64:738-45.
    PubMed     Related articles    Abstract available


    April 2007
  41. SOLFRIZZI V , Capurso C, D'Introno A, Colacicco AM, et al
    Whole-diet approach, Mediterranean diet, and Alzheimer disease.
    Arch Neurol. 2007;64:606.
    PubMed     Related articles   


  42. BOMBOIS S , Maurage CA, Gompel M, Deramecourt V, et al
    Absence of beta-amyloid deposits after immunization in Alzheimer disease with Lewy body dementia.
    Arch Neurol. 2007;64:583-7.
    PubMed     Related articles    Abstract available


  43. LISCIC RM , Storandt M, Cairns NJ, Morris JC, et al
    Clinical and psychometric distinction of frontotemporal and Alzheimer dementias.
    Arch Neurol. 2007;64:535-40.
    PubMed     Related articles    Abstract available


  44. LEE JH , Cheng R, Schupf N, Manly J, et al
    The association between genetic variants in SORL1 and Alzheimer disease in an urban, multiethnic, community-based cohort.
    Arch Neurol. 2007;64:501-6.
    PubMed     Related articles    Abstract available


  45. ROSENBERG RN
    Measuring the risk of Alzheimer disease.
    Arch Neurol. 2007;64:479-80.
    PubMed     Related articles   


    March 2007
  46. MCLACHLAN CS , Chen ML, Lynex CN, Goh DL, et al
    Changes in PDE4D Isoforms in the Hippocampus of a Patient With Advanced Alzheimer Disease.
    Arch Neurol. 2007;64:456-7.
    PubMed     Related articles   


  47. SIMONSEN AH , McGuire J, Hansson O, Zetterberg H, et al
    Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment.
    Arch Neurol. 2007;64:366-70.
    PubMed     Related articles    Abstract available


  48. GRAFF-RADFORD NR , Crook JE, Lucas J, Boeve BF, et al
    Association of low plasma abeta42/abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Arch Neurol. 2007;64:354-62.
    PubMed     Related articles    Abstract available


  49. HOLTZMAN DM
    Pittsburgh compound B retention and verification of amyloid deposition.
    Arch Neurol. 2007;64:315-6.
    PubMed     Related articles   


    February 2007
  50. BEHL P , Bocti C, Swartz RH, Gao F, et al
    Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
    Arch Neurol. 2007;64:266-72.
    PubMed     Related articles    Abstract available


    January 2007
  51. DECARLI C , Frisoni GB, Clark CM, Harvey D, et al
    Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
    Arch Neurol. 2007;64:108-15.
    PubMed     Related articles    Abstract available


  52. RAZAY G , Vreugdenhil A, Wilcock G
    The metabolic syndrome and Alzheimer disease.
    Arch Neurol. 2007;64:93-6.
    PubMed     Related articles    Abstract available


  53. LUCHSINGER JA , Tang MX, Miller J, Green R, et al
    Relation of higher folate intake to lower risk of Alzheimer disease in the elderly.
    Arch Neurol. 2007;64:86-92.
    PubMed     Related articles    Abstract available


    December 2006
  54. SABBAGH MN , Shah F, Reid RT, Sue L, et al
    Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
    Arch Neurol. 2006;63:1771-6.
    PubMed     Related articles    Abstract available


  55. AGGARWAL NT , Wilson RS, Beck TL, Bienias JL, et al
    Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease.
    Arch Neurol. 2006;63:1763-9.
    PubMed     Related articles    Abstract available


    November 2006
  56. COTELLI M , Manenti R, Cappa SF, Geroldi C, et al
    Effect of Transcranial Magnetic Stimulation on Action Naming in Patients With Alzheimer Disease.
    Arch Neurol. 2006;63:1602-1604.
    PubMed     Related articles    Abstract available


  57. LEE JH , Cheng R, Santana V, Williamson J, et al
    Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease.
    Arch Neurol. 2006;63:1591-8.
    PubMed     Related articles    Abstract available


  58. OLARTE L , Schupf N, Lee JH, Tang MX, et al
    Apolipoprotein E {varepsilon}4 and Age at Onset of Sporadic and Familial Alzheimer Disease in Caribbean Hispanics.
    Arch Neurol. 2006;63:1586-1590.
    PubMed     Related articles    Abstract available


  59. AKOMOLAFE A , Beiser A, Meigs JB, Au R, et al
    Diabetes mellitus and risk of developing Alzheimer disease: results from the framingham study.
    Arch Neurol. 2006;63:1551-5.
    PubMed     Related articles    Abstract available


  60. SCHAEFER EJ , Bongard V, Beiser AS, Lamon-Fava S, et al
    Plasma phosphatidylcholine docosahexaenoic Acid content and risk of dementia and Alzheimer disease: the framingham heart study.
    Arch Neurol. 2006;63:1545-50.
    PubMed     Related articles    Abstract available


  61. MORRIS MC
    Docosahexaenoic Acid and Alzheimer disease.
    Arch Neurol. 2006;63:1527-8.
    PubMed     Related articles   


    October 2006
  62. SCARMEAS N , Stern Y, Mayeux R, Luchsinger JA, et al
    Mediterranean Diet, Alzheimer Disease, and Vascular Mediation.
    Arch Neurol. 2006;.
    PubMed     Related articles    Abstract available


  63. REYES AJ
    Potassium-retaining diuretics and incident Alzheimer disease.
    Arch Neurol. 2006;63:1507.
    PubMed     Related articles   


  64. STAVITSKY K , Brickman AM, Scarmeas N, Torgan RL, et al
    The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease.
    Arch Neurol. 2006;63:1450-6.
    PubMed     Related articles    Abstract available


  65. BARNES J , Whitwell JL, Frost C, Josephs KA, et al
    Measurements of the Amygdala and Hippocampus in Pathologically Confirmed Alzheimer Disease and Frontotemporal Lobar Degeneration.
    Arch Neurol. 2006;63:1434-1439.
    PubMed     Related articles    Abstract available


  66. FREUND-LEVI Y , Eriksdotter-Jonhagen M, Cederholm T, Basun H, et al
    {omega}-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD Study: A Randomized Double-blind Trial.
    Arch Neurol. 2006;63:1402-8.
    PubMed     Related articles    Abstract available


  67. ROSENMANN H , Grigoriadis N, Karussis D, Boimel M, et al
    Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein.
    Arch Neurol. 2006;63:1459-67.
    PubMed     Related articles    Abstract available


    September 2006
  68. JOHNSON DK , Wilkins CH, Morris JC
    Accelerated weight loss may precede diagnosis in Alzheimer disease.
    Arch Neurol. 2006;63:1312-7.
    PubMed     Related articles    Abstract available


  69. BRICKELL KL , Steinbart EJ, Rumbaugh M, Payami H, et al
    Early-onset Alzheimer disease in families with late-onset Alzheimer disease: a potential important subtype of familial Alzheimer disease.
    Arch Neurol. 2006;63:1307-11.
    PubMed     Related articles    Abstract available


    August 2006
  70. RAMOS EM , Lin MT, Larson EB, Maezawa I, et al
    Tumor necrosis factor alpha and interleukin 10 promoter region polymorphisms and risk of late-onset Alzheimer disease.
    Arch Neurol. 2006;63:1165-9.
    PubMed     Related articles    Abstract available


    July 2006
  71. ROSENBERG RN
    Treating Alzheimer disease: time matters.
    Arch Neurol. 2006;63:926-8.
    PubMed     Related articles   


  72. SCHNEIDER LS
    Open-label extension studies and misinformation.
    Arch Neurol. 2006;63:1036.
    PubMed     Related articles   


    June 2006
  73. POWELL MR , Smith GE, Knopman DS, Parisi JE, et al
    Cognitive measures predict pathologic Alzheimer disease.
    Arch Neurol. 2006;63:865-8.
    PubMed     Related articles    Abstract available


  74. KRASNIANSKI A , Meissner B, Schulz-Schaeffer W, Kallenberg K, et al
    Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Arch Neurol. 2006;63:876-80.
    PubMed     Related articles    Abstract available


    May 2006
  75. APOSTOLOVA LG , Dutton RA, Dinov ID, Hayashi KM, et al
    Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
    Arch Neurol. 2006;63:693-9.
    PubMed     Related articles    Abstract available


  76. HANSEN LA
    The neuropathology of aging, mild cognitive impairment, and Alzheimer disease.
    Arch Neurol. 2006;63:647-8.
    PubMed     Related articles   


  77. HOFFMAN SNYDER C , Mishark KJ, Caviness JN, Drazkowski JF, et al
    Nonvasculitic autoimmune inflammatory meningoencephalitis imitating Creutzfeldt-Jakob disease.
    Arch Neurol. 2006;63:766-8.
    PubMed     Related articles    Abstract available


  78. JICHA GA , Parisi JE, Dickson DW, Johnson K, et al
    Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
    Arch Neurol. 2006;63:674-81.
    PubMed     Related articles    Abstract available


  79. PETERSEN RC , Parisi JE, Dickson DW, Johnson KA, et al
    Neuropathologic features of amnestic mild cognitive impairment.
    Arch Neurol. 2006;63:665-72.
    PubMed     Related articles    Abstract available


  80. VINTERS HV
    Neuropathology of amnestic mild cognitive impairment.
    Arch Neurol. 2006;63:645-6.
    PubMed     Related articles   


    April 2006
  81. GILL SS
    Delusions and hallucinations in Alzheimer disease.
    Arch Neurol. 2006;63:627.
    PubMed     Related articles   


  82. GALIMBERTI D , Schoonenboom N, Scheltens P, Fenoglio C, et al
    Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.
    Arch Neurol. 2006;63:538-43.
    PubMed     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Bernd Sebastian Kamps website.

   Design: